Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2006-05-30
2006-05-30
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C544S279000, C544S244000, C544S117000, C514S264110, C514S234200
Reexamination Certificate
active
07053070
ABSTRACT:
Disclosed are compounds of the formulawherein R2, R5, R6, R7, and R8are as defined herein. These compounds and their pharmaceutical compositions are useful for treating cell proliferative disorders, such as cancer and restenosis. These compounds are potent inhibitors of cdks and growth factor-mediated kinases.
REFERENCES:
patent: 5620981 (1997-04-01), Blankley et al.
patent: 5733913 (1998-03-01), Blankley et al.
patent: 5952342 (1999-09-01), Blankley et al.
patent: 2003/0149001 (2003-08-01), Barvian et al.
patent: 2003/0171584 (2003-09-01), Chen et al.
patent: 2004/0224958 (2004-11-01), Booth et al.
patent: WO 99/61444 (1999-12-01), None
patent: WO 200170741 (2001-09-01), None
J. M. Hamby, et al., “Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors”, J. Med. Chem., 1997, pp 2296-2303, vol. 40, No. 15.
S. Trumpp-Kallmeyer, et al., “Development of a Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3-d]pyrimidine Inhibitors”, J. Med. Chem., 1998, pp1752-1763, vol. 41, No. 11.
C. J. Connolly, et al., “Discovery and Structure-Activity Studies of a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors”, Bioorg. Med. Chem. Letters, 1997, pp 2415-2420, vol. 7, No. 18.
M. R. Barvian, et al., “Preparation of N,N′-Bis9aryl)guanidines from Electron Deficient Amines Via Masked Carbodiimides”, Tetrahedron Letters, 1997, pp 6799-6802, vol. 38, No. 39.
Booth Richard John
Dobrusin Ellen Myra
Josyula Vara Prasad Venkata Nagendra
Mc Namara Dennis Joseph
Toogood Peter Laurence
Berch Mark L.
Hsu Wendy L.
Warner-Lambert & Company
LandOfFree
Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3652477